| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NHS | Common Stock | Purchase | $46,238 | +5,000 | +50% | $9.25 | 15,000 | 06 Jun 2022 | Direct | F1, F2 |
| transaction | NHS | Common Stock | Purchase | $45,714 | +5,000 | +33% | $9.14 | 20,000 | 07 Jun 2022 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The shares were purchased in separate transactions. The range of prices for the transactions reported on this line was $9.22 to $9.29. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| F2 | On May 19, 2022, the Reporting Person filed a Form 4 reporting an acquisition of 5,000 shares of common stock that did not in fact occur due to administrative error. As of May 19, 2022, the Reporting Person owned only 10,000 shares of common stock. Following the transaction on June 6, 2022 reported in this Form 4, the Reporting Person owned 15,000 shares of common stock. |
| F3 | The shares were purchased in separate transactions. The range of prices for the transactions reported on this line was $9.13 to $9.15. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |